Related Experiment Videos
[Pathologic feature and diagnosis of pulmonary alveolar proteinosis]
Zhi-lan Meng1, Hong-rui Liu, Zhi-yong Liang
1Pathologic features and diagnosis of pulmonary alveolar proteinosis.
Objective:
To describe the pathologic features and diagnostic algorithm of pulmonary alveolar proteinosis (PAP).
Methods:
Thirty-nine biopsy and postmortem cases of PAP were studied by light microscopy and histochemical staining using periodic acid-Schiff (with digestion) (PAS-D), mucicarmine (with digestion) (mucicarmine-D) and alcian blue.
Results:
Histologically, the affected lung tissue displayed the following characteristic features: (1) alveoli and some of the small bronchioles were filled with eosinophilic and fine granular proteinaceous material with needle-like clefts; (2) proteinaceous material was seen admixed with various numbers of degenerated and sometimes exfoliated pneumocytes; (3) pneumocytes were hyperplastic; (4) alveolar capillaries and alveolar septa had become hyperemic, but pulmonary interstitial inflammation was not obvious; (5) no significant inflammation was identified in the bronchial wall; (6) compensating emphysema was noted in the surrounding lung parenchyma. Fragments of eosinophilic, finely granular proteinaceous material with needle-like clefts were also found in the bronchoalveolar lavage fluid under light microscopy. The proteinaceous material was stained red by PAS-D. The staining for mucicarmine-D was negative, while alcian blue staining was either weakly positive (faint blue staining) or negative. Pathologic examination of lung biopsies and bronchoalveolar lavage fluid thus remaines the gold standard for diagnosis of PAP.
Conclusions:
Identification of homogeneous, eosinophilic, finely granular and PAS-D-positive proteinaceous material with needle-like clefts in alveolar spaces or bronchoalveolar lavage fluid is of diagnostic importance in PAP. Bronchoalveolar lavage, being a relatively safe and non-invasive procedure, can be a useful adjunct in arriving at the final conclusion.
Insights
Pulmonary alveolar proteinosis (PAP) is diagnosed by identifying proteinaceous material in the lungs or lavage fluid. This material is eosinophilic, granular, PAS-D-positive, and has needle-like clefts, confirming PAP.
Area of Science:
- Pulmonary pathology
- Histopathology
- Respiratory medicine
Context:
- Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by the accumulation of surfactant-associated proteins and lipids in the alveoli.
- Accurate diagnosis is crucial for appropriate management and patient outcomes.
- Traditional diagnostic methods often involve invasive procedures.
Purpose:
- To delineate the characteristic pathologic features of pulmonary alveolar proteinosis (PAP).
- To establish a diagnostic algorithm for PAP based on histopathologic findings.
- To evaluate the utility of bronchoalveolar lavage (BAL) in diagnosing PAP.
Summary:
- Histologic examination of lung biopsies and postmortem cases revealed characteristic features of PAP, including alveoli filled with eosinophilic, granular proteinaceous material with needle-like clefts.
- This material stained positive with periodic acid-Schiff with digestion (PAS-D), negative with mucicarmine-D, and variably with alcian blue.
- Fragments of similar material were identified in bronchoalveolar lavage fluid, supporting its diagnostic value.
Impact:
- Pathologic examination of lung biopsies and BAL fluid are confirmed as the gold standard for PAP diagnosis.
- Bronchoalveolar lavage offers a relatively safe and non-invasive method for diagnosing PAP.
- Understanding these features aids in differentiating PAP from other interstitial lung diseases.
Related Concept Videos
Chronic Obstructive Pulmonary Disease II: Emphysema
Pneumonia II: Pathophysiology
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Atypical Pneumonia
Pulmonary Edema II: Pathophysiology